Sutro Biopharma

STRONasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$420.558 M

$25.38 +5.09%

Close of 7 Aug 2026

Revenue

$102.5M

#2505 by revenue

Earnings

-$191.0M

Loss-making

Shares outstanding

16,567,238

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#75OcugenOCGN$434.1M
#76Scribe TherapeuticsSCTX$420.7M
#77Sutro BiopharmaSTRO$420.6M
#78C4 TherapeuticsCCCC$412.4M
#79Fennec PharmaceuticalsFENC$403.8M

Where these numbers come from

Share counts and financials for Sutro Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.